ALGEN
GENOWAY
Stock Euronext / Paris – Stock Market Prices, News & Analysis
GENOWAY is a biotechnology company focused on the development and commercialization of genetically modified models for biomedical research.
GENOWAY
ALGEN
GENOWAY is a biotechnology company focused on the development and commercialization of genetically modified models for biomedical research.
Price history of GENOWAY
Price history of GENOWAY
Performance & Momentum
Strategic Analysis
GENOWAY • 2026
Genoway positions itself as a niche player in biotechnology, offering genetically modified models for biomedical research, thereby targeting a specialized and demanding segment. Its business model is based on technological innovation and the commercialization of unique solutions to accelerate scientific research.
- Deep expertise in genetics applied to biomedical research
- Differentiated technological offering with tailor-made models
- Focus on a growing European biotech market
- Deteriorated share performance over the medium and long term
- Lack of recent media catalysts or new developments
Despite relatively strong technical momentum, the trend is held back by a prolonged decline in the share price, reflecting a lack of commercial momentum or recent financial visibility. This suggests caution for investors, with any upside potential requiring confirmation through concrete operational progress.
Similar stocks to GENOWAY
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
